Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Topical finasteride is an effective and safer treatment for male hair loss.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Finasteride works better for hair loss in patients 26 or younger.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Polycystic ovary syndrome (PCOS) is a major health issue for women in Egypt, affecting 14% of fertile women and 37.5% of infertile women.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Androgen levels do not determine the type of PCOS symptoms in young females.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Alopecia linked to higher anxiety and personality disorders.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.